Sulforaphane Attenuates Nonalcoholic Fatty Liver Disease by Inhibiting Hepatic Steatosis and Apoptosis

Nonalcoholic fatty liver disease (NAFLD) is characterized by lipotoxicity and ectopic lipid deposition within hepatocytes. Sulforaphane (SFA), an active compound used for inhibiting tumors, was found to have the potency to improve lipid metabolism. However, its molecular mechanisms on ameliorating N...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Jinwang, Xie, Siyu, Teng, Wendi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746639/
https://www.ncbi.nlm.nih.gov/pubmed/35010950
http://dx.doi.org/10.3390/nu14010076

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8746639/
https://www.ncbi.nlm.nih.gov/pubmed/35010950
http://dx.doi.org/10.3390/nu14010076

Ejemplares similares